Erdafitinib Powder CAS 1346242-81-6: Technical Data and Product Guide

Product Description

Erdafitinib is a chemically defined small-molecule compound with the CAS number 1346242-81-6 and molecular formula C25H30N6O2. It is associated with the inhibition of fibroblast growth factor receptors (FGFRs), proteins that participate in cellular signaling and regulate various biological processes.

For customers purchasing chemical materials, understanding the product's identity and specifications is an important first step. The material described in this listing is supplied in powder form, with a stated purity exceeding 99%. HPLC-UV is the analytical method specified in the available product information.

Erdafitinib has an established background in FGFR-targeted cancer treatment and is discussed in research concerning receptor signaling. However, the grade and documentation of a particular material determine whether it is suitable for a specific purpose. Buyers should not assume that a technical-grade product meets pharmaceutical manufacturing or clinical requirements.

Technical Specifications

Understanding Product Quality

Chemical Identification

The CAS number serves as a standardized reference for identifying Erdafitinib in product catalogs, purchasing records, and technical communications. The molecular formula provides additional information about the atoms present in the molecule.

When comparing suppliers, buyers should check these identifiers against the product documentation. A matching product name alone is not enough to establish that two materials have identical specifications.

Purity and Analytical Reports

The listed purity is greater than 99%. To evaluate this specification, buyers should request the applicable certificate of analysis (COA) and check the reported test results.

HPLC-UV combines chromatographic separation with ultraviolet detection. It can help assess the composition of a sample under defined analytical conditions. The exact method and acceptance criteria matter when interpreting the reported result.

A purity figure should not be treated as a complete quality assessment. Other characteristics may require additional testing, depending on the intended application and required standards.

Physical Appearance

The supplied information describes the product as a white powder. Appearance can support routine incoming inspection, but visual assessment cannot confirm chemical identity or purity. Any differences from the expected appearance should be evaluated using the relevant quality procedures.

Research Background

FGFRs are receptors involved in transmitting signals between cells and within cellular systems. Researchers investigate these pathways to understand their roles in cell behavior and related biological processes.

Erdafitinib is relevant to this field because it inhibits certain FGFR proteins. Its mechanism has also contributed to scientific interest in targeted approaches to diseases involving altered FGFR signaling.

For professional research settings, the choice of material should be based on documented identity, purity, grade, and suitability for the planned work. A product listing provides an initial reference, while technical documents supply the information needed for a more detailed assessment.

This product information is intended for chemical identification and sourcing purposes. It does not establish suitability for human administration, clinical use, or pharmaceutical manufacturing.

Packaging, Storage and Handling

Package selection depends on the required quantity, handling procedures, and storage facilities. The listed formats range from small quantities to larger bulk packages, but actual availability should be confirmed before ordering.

The supplied product data specify storage at 2–8°C in a sealed container protected from light. Buyers should verify these conditions against the current product-specific documentation before establishing storage procedures.

Handle chemical powders carefully and follow the relevant safety data sheet (SDS). Appropriate protective equipment, controlled handling, and secure labeling should be used according to the documented hazards.

A two-year retest period has been provided in the original specifications, but it should only be published as a confirmed product attribute if supported by appropriate stability documentation.

Ordering and Delivery

To request a quotation, buyers should provide the desired quantity, preferred packaging, destination country, and required technical documents. These details help determine available stock, suitable packaging, and delivery arrangements.

The estimated lead time is 5–10 days, subject to confirmation. Shipping options depend on destination, carrier acceptance, customs requirements, and applicable transport regulations.

For larger orders or customized packaging, confirming availability and specifications before payment can help avoid misunderstandings. Buyers should review the final quotation and relevant product documentation before proceeding.

Frequently Asked Questions

What is Erdafitinib CAS 1346242-81-6?

It is a small-molecule compound associated with FGFR inhibition and related scientific research.

What is its molecular formula?

Its molecular formula is C25H30N6O2.

What purity is listed?

The supplied specification states greater than 99% purity. The actual result should be checked against the relevant batch COA.

How is the product analyzed?

HPLC-UV is the analytical method listed in the supplied product data.

What packaging formats can be requested?

Listed options include 1 g, 100 g, 1 kg, and 25 kg formats, subject to confirmation.

How can buyers obtain technical information?

Provide the product name, required quantity, destination, and documentation requirements to request confirmation of the available specifications and supply arrangements.

Summary

Erdafitinib CAS 1346242-81-6 is identified by the molecular formula C25H30N6O2 and is supplied according to specifications describing a powder with a stated purity above 99%. HPLC-UV is the listed analytical method. Buyers should confirm batch-specific quality results, storage conditions, packaging availability, and applicable regulatory requirements before placing an order.